ArticleEClinicalMedicine2023

Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.

Valentin Barsan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.